DAP:ETR
Danaher Corp
၁၉၈.၁၀ €
၀.၀၀%
(၀.၀၀) 1D
စက် ၂၉, GMT+၂ ၁၇:၃၅:၃၃ · EUR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DAP...
Open
၁၉၉.၀၅ €
High
၂၀၀.၀၀ €
Low
၁၉၆.၆၀ €
Mkt. cap
ဋေ ၁.၅၉ သ
Avg. vol.
၆၁၀.၀၀
Volume
၅၉၉.၀၀
52-wk high
၂၀၈.၃၀ €
52-wk low
၁၃၈.၂၀ €
No. of employees
၆ သောင်း
Open
၁၉၉.၀၅ €
High
၂၀၀.၀၀ €
Low
၁၉၆.၆၀ €
Mkt. cap
ဋေ ၁.၅၉ သ
Avg. vol.
၆၁၀.၀၀
Volume
၅၉၉.၀၀
52-wk high
၂၀၈.၃၀ €
52-wk low
၁၃၈.၂၀ €
No. of employees
၆ သောင်း
News stories
From web sources and news partners
AD HOC NEWS
·
ပြီးခဲ့သည့် ၃ နာရီ
Danaher stock after-hours at EUR 198.88: minus 0.10 percent versus the Lang & Schwarz prior close
Investing.com Canada
·
ပြီးခဲ့သည့် ၁ ရက်
Form 4 Danaher Corporation For: 28 September By Investing.com
Profile
Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology, which develops products for the development of therapeutics; life sciences, which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics, which develops instruments, consumables, and software and services to diagnose diseases. Danaher was founded in 1984 by brothers Steven Rales and Mitchell Rales; it was named after Danaher Creek in Western Montana, where the brothers came up with the idea for the company while fishing.
The company is ranked 180th on the Fortune 500 and 241st on the Forbes Global 2000. Wikipedia
About Danaher Corp